Research Article
Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma
Table 6
Multivariate analysis (mOS).
| Parameters | Hazard ratio | 95% confidence interval | value |
| Infusion of CD8+TIL numbers ( vs. ) | 5.30 | (2.80, 10.03) | <0.0001 | Infusion of CD8+TIL percentage (≥60% vs. <60%) | 5.88 | (2.85, 12.14) | <0.0001 | Infusion of CD8+PD1+TIL percentage (≥10% vs. <10%) | 6.38 | (2.70, 15.08) | <0.0001 | Infusion of CD4+FoxP3+TIL percentage (≥20% vs. <20%) | 4.87 | (2.56, 9.84) | <0.0001 |
|
|